Significantly, IR‐LND@Lip proficiently reversed the RT‐induced upregulation of PD‐L1/TGF‐β proteins and counteracted the fibrotic tumor microenvironment (Figure 6B; Figure S24, Supporting Information), providing further confirmation of its synergistic effect in enhancing radio‐immunotherapy. The gene discussed is TGFB1; the disease is neoplasm.